“Omalizumab As an Adjuvant Therapy for Treating Severe Atopic Dermatitis in Children. A Series of Cases”. Revista Alergia México 66, no. 3 (June 27, 2019): 282–291. Accessed September 23, 2026. https://ojs.revistaalergia.mx/ojs/index.php/ram/article/view/401.